Ledger entry · candidate
Empagliflozin → Acute kidney injury — Audit-grade candidate (class scan)
Drug: empagliflozin · AE: Acute kidney injury
Discovered via class scan of SGLT2 inhibitors. PRR = 3.05, n = 583 cases.
Disproportionality
- PRR: 3.0510268567368217
- Yates χ2: n/a
- Cases (case-drug + AE): n = 583
- Verdict:
PASSES_ALL_GATES — PRR=3.05 (95% CI 2.82–3.31), n=583 cases; flagged for clinical expert review, NOT for external escalation without manual verification
Top reactions in cohort
| MedDRA PT | n |
|---|
| No reactions surfaced in cohort. |
Source: openFDA FAERS, Caliper Engine v0. Pre-registration sha1 locked at submission time; ledger entry signed with platform Ed25519 key.